76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Elanco Animal Health Inc
Closed
SectorHealthcare
14.3 3.92
Overview
Share price change
24h
Min
14.02
Max
14.36
Income | 75M 67M |
|---|---|
Sales | 173M 1.2B |
P/E Sector Avg | 17.8 50.291 |
EPS | 0.37 |
Profit margin | 5.616 |
Employees | 9,000 |
EBITDA | 86M 261M |
Recommendations | Buy |
|---|---|
12 Months Forecast | -2.47% downside |
Next Earnings | 7 Aug 2025 |
|---|
Market Cap | 1.8B 6.6B |
|---|---|
Previous open | 10.38 |
Previous close | 14.3 |
Technical Score
By Trading Central
Confidence
Bullish Evidence
Elanco Animal Health Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Elanco Animal Health Inc Forecast
Price Target
By TipRanks
-2.47% downside
12 Months Forecast
Average 13.42 USD -2.47%
High 16 USD
Low 10 USD
Based on 8 Wall Street analysts offering 12 month price targets forElanco Animal Health Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Elanco Animal Health Inc
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
